Christina L. Stallings

Focusing on high-impact outcomes in the field of infectious diseases, Christina L. Stallings serves as a Professor of Molecular Microbiology at Washington University School of Medicine. Her research is dedicated to unraveling the complex molecular pathogenesis of Mycobacterium tuberculosis and related infections. Dr. Stallings is particularly interested in understanding the adaptive mechanisms employed by Mycobacteria to endure host-inflicted stresses and maintain persistent infections. Her laboratory employs a multidisciplinary approach, integrating in vivo disease modeling, molecular biology, and biochemistry to explore these phenomena. The ultimate goal of her research is to uncover fundamental biological processes that can inform the development of innovative therapeutic strategies aimed at treating mycobacterial infections. Dr. Stallings is at the forefront of efforts to identify novel agents capable of combating multi-drug and extensively drug-resistant strains of M. tuberculosis, a pressing global health challenge. In addition to her research endeavors, Dr. Stallings is deeply committed to education and mentorship. She actively seeks opportunities to mentor PhD and MSTP students who have a keen interest in her research area, fostering the next generation of scientists in the field of molecular microbiology. Her mentorship is characterized by a supportive and collaborative environment, encouraging students to engage in cutting-edge research and develop their scientific acumen. Dr. Stallings' work has significant implications for understanding the molecular underpinnings of tuberculosis and other mycobacterial infections, with the potential to transform therapeutic approaches and improve patient outcomes. Her contributions to the field are recognized both nationally and internationally, and she continues to be a leading voice in the scientific community. Through her research and mentorship, Dr. Stallings exemplifies a commitment to advancing scientific knowledge and addressing critical public health issues. Her work not only enhances our understanding of mycobacterial infections but also paves the way for the development of effective treatments that could save countless lives worldwide.